Jasper Therapeutics

IPO

Jasper Therapeutics is a biotech company in Redwood City, United States. It has raised $181.0M across 3 rounds, most recently a $132.0M Private Equity in August 2026.

Headquarters
Redwood City
Employees
51–200
Total Funding
$181.0M
Last Round
$132.0M Private EquityAug 2026
Rounds
3
Type
Public
Ticker
JSPR · NASDAQ

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Jasper Therapeutics is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117), as a therapeutic to deplete mast cells and treat chronic mast cell diseases such as chronic urticaria and asthma. The company is currently conducting clinical studies of briquilimab in patients with CSU or CIndU, and is planning to initiate a clinical study in asthma patients. To date, briquilimab has demonstrated an efficacy and safety profile in over 160 dosed subjects and healthy volunteers.

Summary

It lists 51–200 employees. It has raised $181.0M in total across 3 rounds, most recently a $132.0M Private Equity round in Aug 2026. Investors include Roche Venture Fund, Abingworth Bioventures and Alexandria Venture Investments.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Private EquityPrivate EquityAug 2026
$132.0M

Sign up to see all 3 events

Funding: Series A through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Jasper Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/jasper-therapeutics"><img src="https://indexed.vc/api/badge/company/jasper-therapeutics" alt="Jasper Therapeutics on Indexed.vc" width="260" height="76" /></a>